179 results on '"Dischinger, Ulrich"'
Search Results
2. Efficacy and safety of radiation therapy in advanced adrenocortical carcinoma
3. Obesity and its comorbidities, current treatment options and future perspectives: Challenging bariatric surgery?
4. Effect of bariatric surgery on cardio-psycho-metabolic outcomes in severe obesity: A randomized controlled trial
5. Simplified urinary steroid profiling by LC-MS as diagnostic tool for malignancy in adrenocortical tumors
6. Hypothalamic integrity is necessary for sustained weight loss after bariatric surgery: A prospective, cross-sectional study
7. THU-269-YI Effects of semaglutide, Peptide YY3-36 and empagliflozin on metabolic dysfunctions-associated fatty steatotic liver disease in diet-induced obese rats with chronic nitric oxide synthaseinhibition
8. Assessing Lateralization Index of Adrenal Venous Sampling for Surgical Indication in Primary Aldosteronism
9. Prediction of adrenal masses nature through texture analysis and deep learning: Preliminary results from ENS@T RADIO-AI multicentric study
10. Comparison of metyrapone, osilodrostat and ketoconazole in the therapy of endogenous Cushing's syndrome: The MOSKETEER study
11. Effects of semaglutide, Peptide YY3-36 and empagliflozin on metabolic dysfunction associated fatty steatotic liver disease in diet-induced obese rats with chronic nitric oxide synthase-inhibition
12. Transcriptome of periadrenal and subcutaneous fat in patients with hyperaldosteronism in comparison to patients with non-functional adenomas
13. Early detection of recurrence and progress using serum steroid profiling by LC-MS/MS in patients with adrenocortical carcinoma
14. Effects of antagonists of the NPY-2 receptor, semaglutide, PYY3-36, and empagliflozin on metabolic dysfunction-associated steatotic liver disease in diet-induced obese rats
15. Neues aus der Endokrinologie/Diabetologie
16. Characteristics of Patients Lost to Follow-up after Bariatric Surgery.
17. Disruptive effects of plasticizers bisphenol A, F, and S on steroidogenesis of adrenocortical cells.
18. Screening for Primary Aldosteronism by Mass Spectrometry Versus Immunoassay Measurements of Aldosterone: A Prospective Within-Patient Study.
19. The Value of Local Therapies in Advanced Adrenocortical Carcinoma
20. GLP-1 and PYY for the treatment of obesity: use of agonists and antagonists in diet-induced rats, a pilot study
21. Association of preclinical blood glucose with hospitalization rate and in‐hospital mortality: A single‐center retrospective cohort study
22. Current Evidence on Local Therapies in Advanced Adrenocortical Carcinoma
23. Effect of mild cortisol cosecretion on body composition and metabolic parameters in patients with primary hyperaldosteronism
24. Simulating the Post-gastric Bypass Intestinal Microenvironment Uncovers a Barrier-Stabilizing Role for FXR
25. Susceptibility of Melanoma Cells to Targeted Therapy Correlates with Protection by Blood Neutrophils.
26. Early Detection of Recurrence and Progress Using Serum Steroid Profiling by LC–MS/MS in Patients with Adrenocortical Carcinoma
27. Responses to systemic therapy in metastatic pheochromocytoma/paraganglioma - A retrospective multi-center cohort study
28. Endocrine Disruptors: Focus on the Adrenal Cortex
29. GLP-1 and PYY3-36 reduce high-fat food preference additively after Roux-en-Y gastric bypass in diet-induced obese rats
30. Effects of NPY-2 Receptor Antagonists, Semaglutide, PYY 3-36 , and Empagliflozin on Early MASLD in Diet-Induced Obese Rats.
31. Endocrine Disruptors: Focus on the Adrenal Cortex.
32. Early Detection of Recurrence and Progress Using Serum Steroid Profiling by LC–MS/MS in Patients with Adrenocortical Carcinoma.
33. Comparison of metyrapone, osilodrostat and ketoconazole in the short-term therapy of endogenous Cushing's syndrome: Preliminary results of the Mosketeer study
34. Bisphenols in adrenocortical cell culture
35. Metabolic heterogeneity in adrenocortical carcinoma impacts patient outcomes
36. Performance of DNA-based biomarkers for classification of adrenocortical carcinoma: a prognostic study
37. Clinical relevance of targeted sequencing in paraffin-embedded samples for prognostic classification of adrenocortical carcinoma
38. Bisphenols in adrenocortical cell culture: Further evidence for the relevance of endocrine disruptive chemicals for adrenal gland functionality
39. Effects of semaglutide, PYY3-36, and empagliflozin on the adrenal gland transcriptome in diet induced obese rats
40. Effects of semaglutide, PYY3-36, antagonists of the GLP-1/NPY-Y2 receptors, and empagliflozin on non-alcoholic fatty liver disease
41. Effects of a combinatory treatment with semaglutide and a NPY Y2 receptor selective PYY 3-36 analogue in diet-induced obese rats: surpassing bariatric surgery?
42. Description of 38 novel ARMC5 variants and review of the literature: the updated mutational landscape of ARMC5 in Bilateral Macronodular Adrenocortical Disease
43. An Open-Label Extension Study to Evaluate the Safety of Long-term Use of Relacorilant in Patients With Endogenous Cushing Syndrome
44. Responses to systemic therapy in metastatic pheochromocytoma/paraganglioma: a retrospective multicenter cohort study.
45. Changes in Plasma Metabolomic Profile Following Bariatric Surgery, Lifestyle Intervention or Diet Restriction—Insights from Human and Rat Studies
46. Volume–outcome relationship in adrenal surgery from 2009-2017 in Germany—a retrospective study
47. Efficacy and safety of radiation therapy in advanced adrenocortical carcinoma
48. Endokrine Disruptoren
49. Screening for primary aldosteronism using steroidomics with machine learning and comparison to aldosterone:renin ratios
50. Effects of a combinatory treatment with semaglutide and a selective PYY-Y2 receptor analogue in diet-induced obese rats: Surpassing bariatric surgery? (#64)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.